<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Current diagnostic classification criteria recommend elevated titres of anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (aCL) and/or anti-beta(2)GPI antibody by ELISA IgG or IgM and/or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) to confirm <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>Although IgA aPL antibodies have been shown to be pathogenic in animal models of APS, their clinical significance has remained elusive </plain></SENT>
<SENT sid="2" pm="."><plain>We report four cases of exclusive IgA anti-beta(2)GPI antibody sero-positivity with concomitant clinical manifestations associated with APS </plain></SENT>
<SENT sid="3" pm="."><plain>Four of the five patients were LA negative </plain></SENT>
<SENT sid="4" pm="."><plain>1) Thirty-eight-year-old African-American female with SLE presented with resolving digital <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Serum IgA anti-beta(2)GPI antibody titres were 118.5 SAU (<z:mpath ids='MPATH_458'>normal</z:mpath> range: 0-20 SAU) </plain></SENT>
<SENT sid="6" pm="."><plain>2) Twenty-seven-year-old African-American woman with SLE was evaluated for recent <z:hpo ids='HP_0003674'>onset</z:hpo> of severe <z:hpo ids='HP_0002315'>headaches</z:hpo>, unresponsive to <z:chebi fb="29" ids="35480">analgesics</z:chebi> and anti-<z:hpo ids='HP_0002076'>migraine</z:hpo> medications </plain></SENT>
<SENT sid="7" pm="."><plain>MRI of the brain revealed hyper-intensities in the white matter in the frontal lobes </plain></SENT>
<SENT sid="8" pm="."><plain>Serum IgA anti-beta(2)GPI antibody titres were 29.1 Standard A Units (SAU) </plain></SENT>
<SENT sid="9" pm="."><plain>3) Thirty-two-year-old Hispanic female with history of two unexplained <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> and negative serologies for SLE </plain></SENT>
<SENT sid="10" pm="."><plain>Serum IgA anti-beta(2)GPI antibody titres were 102.0 SAU </plain></SENT>
<SENT sid="11" pm="."><plain>4) Twenty-five-year-old white female with history of recent unexplained <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage</z:e> in the 11th week of gestation and associated complaints of numbness and tingling in her hands </plain></SENT>
<SENT sid="12" pm="."><plain>Her IgA anti-beta(2)GPI antibody titre was 62.0 SAU </plain></SENT>
<SENT sid="13" pm="."><plain>5) Twenty-five-year-old African-American woman with SLE, positive for anti-Ro antibodies with a history of ischemic fingers, a pregnancy loss and recent pregnancy complicated due to pre-<z:hpo ids='HP_0100601'>eclampsia</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>Her LA was positive and her IgA anti-beta(2)GPI antibody titer was 186.0 SAU </plain></SENT>
<SENT sid="15" pm="."><plain>This case series supports that <z:hpo ids='HP_0003261'>elevated IgA</z:hpo> anti-beta(2)GPI antibody titres may identify additional patients who have clinical features of APS but who do not meet current diagnostic criteria </plain></SENT>
</text></document>